A61K 31/416
Condensed with carbocyclic ring systems
Official title: condensed with carbocyclic ring systems, e.g. indazole
A61K31/416 (Condensed with carbocyclic ring systems) appears on 673 US grants and 1,352 published applications in this corpus.
Search patents in A61K- Granted patents
- 673
- Published applications
- 1,352
- Assignees
- 616
- Inventors
- 3,685
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 7 | 0 |
| 2002 | 2 | 8 |
| 2003 | 3 | 23 |
| 2004 | 3 | 32 |
| 2005 | 6 | 40 |
| 2006 | 14 | 27 |
| 2007 | 9 | 37 |
| 2008 | 18 | 18 |
| 2009 | 5 | 28 |
| 2010 | 16 | 39 |
| 2011 | 11 | 32 |
| 2012 | 18 | 39 |
| 2013 | 21 | 59 |
| 2014 | 30 | 63 |
| 2015 | 34 | 68 |
| 2016 | 41 | 66 |
| 2017 | 70 | 84 |
| 2018 | 53 | 85 |
| 2019 | 54 | 78 |
| 2020 | 56 | 64 |
| 2021 | 36 | 71 |
| 2022 | 36 | 66 |
| 2023 | 30 | 84 |
| 2024 | 30 | 73 |
| 2025 | 40 | 78 |
| 2026 | 21 | 90 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Coronavirus main protease inhibitors and methods using same8 Sep 2026US 12,729,190 B2Baylor College of Medicine
- Anticancer combination therapy with N-(1-acryloyl-azetidin-3-yl)-2-((1H-indazol-3-yl)amino)methyl)-1H-imidazole-5-carboxamide inhibitor of KRAS-G12C11 Aug 2026US 12,702,658 B2Astex Therapeutics Limited
- NMT inhibitor treatment of a senescence-associated disease or disorder of the liver28 Jul 2026US 12,691,100 B2Imperial College Innovations Limited
- Small molecule modulators of sigma-1 and sigma-2 receptors and uses thereof28 Jul 2026US 12,692,236 B2Northwestern University
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Selective glucocorticoid receptor modifiers for treating impaired skin wound healing1 Oct 2026US 2026/0294918 A1Akribes Biomedical GmbH
- Cyclic vinyl sulfone wrn inhibitors1 Oct 2026US 2026/0297070 A1Nimbus Wadjet, Inc.
- Ferroptosis inhibitors24 Sep 2026US 2026/0283988 A1Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- Compounds for nos-related cancers and methods of use24 Sep 2026US 2026/0284009 A1Yissum Research Development Company of the Hebrew University of Jerusalem
Most cited
By later US patents
- Pyrazole compound and medicinal composition containing the same142US 7,429,609 B2Eisai R&D Management Co., Ltd. · 2008
- Angiogenesis inhibitors110US 7,166,293 B2Carlsbad Technology, Inc. · 2007
- Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics107US 6,224,857 B1Fidia S.p.A. · 2001
- Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors102US 8,697,887 B2Samumed, LLC · 2014
- Indazolecarboxamide derivatives for the treatment and prevention of malaria93US 7,842,711 B2Sanofi-Aventis · 2010